Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1128/mBio.02134-20 http://scihub22266oqcxt.onion/10.1128/mBio.02134-20 32978312!7520600!32978312     free     free     free       mBio 2020 ; 11 (5): ? Nephropedia Template TP {{tp|p=32978312|t=2020. Antiviral Drug Discovery To Address the COVID-19 Pandemic |pdf=|usr=}}{{32978312}} gab.com Text Antiviral Drug Discovery To Address the COVID-19 Pandemic JO: mBio http://www.kidney.de/pget.php?&tw=1&pmid=32978312 #FOAvip The magnitude of the morbidity and mortality inflicted upon the global population in less than 1 year has driven the inescapable conclusion that the discovery and development of effective antiviral drugs for COVID-19 are urgent and should be prioritized. The antiviral drug discovery programs that emerged for HIV and hepatitis C virus have enabled technology and expertise to accelerate this process for SARS-CoV-2. The description of candidate lead inhibitors for the viral main protease (M(pro)) exemplifies this accelerated approach and reminds us of the needs and opportunities for addressing this pandemic. Twit Text FOAVip Antiviral Drug Discovery To Address the COVID-19 Pandemic ????mBio http://www.kidney.de/pget.php?&tw=1&pmid=32978312 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32978312 #FOAvip English Wikipedia <ref>{{Cite pmid|32978312}}</ref> Antiviral Drug Discovery To Address the COVID-19 Pandemic #MMPMID32978312 Richman DD mBio 2020[Sep]; 11 (5): ? PMID32978312show ga The magnitude of the morbidity and mortality inflicted upon the global population in less than 1 year has driven the inescapable conclusion that the discovery and development of effective antiviral drugs for COVID-19 are urgent and should be prioritized. The antiviral drug discovery programs that emerged for HIV and hepatitis C virus have enabled technology and expertise to accelerate this process for SARS-CoV-2. The description of candidate lead inhibitors for the viral main protease (M(pro)) exemplifies this accelerated approach and reminds us of the needs and opportunities for addressing this pandemic. |*Antiviral Agents[MESH] |*Pandemics[MESH] |*Pneumonia, Viral[MESH] |*Severe Acute Respiratory Syndrome[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology[MESH] |Cysteine Endopeptidases[MESH] |Drug Discovery[MESH] |Humans[MESH] |Indoles[MESH] |SARS-CoV-2[MESH]Antiviral Drug Discovery To Address the COVID-19 Pandemic (epmc).pdf DeepDyve Pubget Overpricing